Outcomes of Thoracic Surgical Oncology Group 103: Multimodality management in risk-stratified patients with lung-limited metastatic colorectal cancerCentral MessagePerspective

Objective: Thoracic Surgery Oncology Group 103 was a prospective multi-institutional trial that aimed to (1) evaluate the role of perioperative chemotherapy for low-risk patients with metastatic colorectal cancer undergoing pulmonary metastasectomy and (2) characterize the impact of surgery on outco...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mara B. Antonoff, MD, Zamaan Hooda, MD, Xiaowen Sun, MS, May Celestino, MD, Nathaniel Evans, MD, Tyler Grenda, MD, MS, Jack Lee, PhD, Reza Mehran, MD, Olugbenga T. Okusanya, MD, Ravi Rajaram, MD, MSc, Thomas Waddell, MD, FRCSC, Garrett Walsh, MD, Jonathan Yeung, MD, Ara Vaporciyan, MD, Kyle G. Mitchell, MD, MSc, Van K. Morris, MD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-04-01
Col·lecció:	JTCVS Open
Matèries:	colorectal carcinoma multimodality therapy pulmonary metastasectomy pulmonary metastases randomized clinical trial
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666273626001257
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!